National Association of Testing Authorities, Australia
Scope of Accreditation
Genetic Technologies Limited
Site
GeneType PTY LTD
Accreditation No.
20432
Site No.
24460
Date of Accreditation
20 Aug 2019
Contact
Dr Gary Goh
P: +61 (03) 84127051
Availability
Services conditionally available to external clients
Supervision
Not Applicable
Scope of Accreditation
GeneType PTY LTD
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Molecular genetics - DNA extraction | Saliva | Viable DNA |
| Molecular genetics - Predictive genetic testing - Targeted genes | Buccal swabs | Polygenic risk score (PRS) - Breast cancer; Polygenic risk score (PRS) - Colorectal cancer |
| Saliva | Polygenic risk score (PRS) - Atrial Fibrillation ; Polygenic risk score (PRS) - Breast cancer; Polygenic risk score (PRS) - Colorectal cancer; Polygenic risk score (PRS) - Coronary artery disease; Polygenic risk score (PRS) - Melanoma; Polygenic risk score (PRS) - Ovarian cancer; Polygenic risk score (PRS) - Pancreatic cancer; Polygenic risk score (PRS) - Prostate cancer; Polygenic risk score (PRS) - Type II diabetes | |
| Molecular genetics/Cytogenetics - Bioinformatic analysis | DNA sequences | Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
20432
Site No.
24460
Print date
08 Dec 2023
END OF SCOPE
